CoffinPOGaleaSAhernJLeonACVlahovDTardiffK.Opiates, cocaine and alcohol combinations in drug overdose deaths in New York City, 1990–98. Addiction2003; 98:739–47.
2.
KerkerBBainbridgeJLiWKennedyJBennaniYAgertonT, The health of the homeless: A report from New York City's Departments of Health and Mental Hygiene and Homeless Services, 2005.
3.
PfeifferMHannaDBBegierEMSepkowitzKATorianLVSackoffJE. Persistent contribution of substance abuse to excess mortality among persons with AIDS in New York City, 1999–2003. Presentation at the 16th International AIDS Conference; 2006 Aug 13–18; Toronto, Ontario, Canada.
4.
BinswangerIASternMFDeyoRAHeagertyPJCheadleAElmoreJG, Release from prison—a high risk of death for former inmates. N Engl J Med2007; 356:157–65.
5.
OchoaKCDavidsonPJEvansJLHahnJAPage-ShaferKMossAR. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend2005; 80:297–302.
6.
BirdSMHutchinsonSJ. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996–99. Addiction2003; 98:185–90.
7.
SeamanSRBrettleRPGoreSM. Mortality from overdose among injecting drug users recently released from prison: Database linkage study. BMJ1998; 316:426–8.
8.
SporerKAKralAH. Prescription naloxone: A novel approach to heroin overdose prevention. Ann Emerg Med2007; 49:172–7.
9.
BacaCTGrantKJ. Take-home naloxone to reduce heroin death. Addiction2005; 100:1823–31.
10.
TracyMPiperTMOmpadDBucciarelliACoffinPOVlahovD, Circumstances of witnessed drug overdose in New York City: Implications for intervention. Drug Alcohol Depend2005; 79:181–90.
11.
LaguTAndersonBJSteinM.Overdoses among friends: Drug users are willing to administer naloxone to others. J Subst Abuse Treat2006; 30:129–33.
12.
RileyDO'HareP.Harm reduction: History, definition, and practice. In: InciardiJAHarrisonLD, editors. Harm reduction: National and international perspectives. Thousand Oaks (CA): Sage; 2000. p. 1–26.
13.
PiperT MarkhamRudenstineSStancliffSShermanSNandiVClearA, Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City. Harm Reduct J2007; 4:3.
NandiAGaleaSAhernJBucciarelliAVlahovDTardiffK.What explains the association between neighborhood-level income inequality and the risk of fatal overdose in New York City?Soc Sci Med2006; 63:662–74.
16.
HembreeCGaleaSAhernJTracyMPiperTMMillerJ, The urban built environment and overdose mortality in New York City neighborhoods. Health Place2005; 11:147–56.
17.
GaleaSWorthingtonNPiperTMNandiVVCurtisMRosenthalDM. Provision of naloxone to injection drug users as an overdose prevention strategy: Early evidence from a pilot study in New York City. J Addic Behav2006; 31:907–12.
CandelasA. Applying national overdose prevention experience to local policy implementation. Presentation at the 6th National Harm Reduction Conference; 2006 Nov 11; Oakland, CA.
21.
Open Society Institute, OSI-Baltimore. Health experts hold forum on highly successful Baltimore overdose prevention program [press release]; 2005 Sep 20 [cited 2006 Nov 17]. Available from: URL: http://www.soros.org/initiatives/baltimore/news/health_20050920
22.
AshtonHHassanZ.Best evidence topic report. Intranasal naloxone in suspected opioid overdose. Emerg Med J2006; 23:221–3.
23.
KellyAMKerrDDietzePPatrickIWalkerTKoutsogiannisZ.Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. Med J Aust2005; 182:24–7.
24.
CoffinPOFullerCVadnaiLBlaneySGaleaSVlahovD.Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City. J Urban Health2003; 80:288–90.